Press Release

  View printer-friendly version

« Back

Collegium to Present at Jefferies and William Blair Conferences

June 2, 2016 at 10:36 AM EDT

CANTON, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the following investor conferences in June:

  • Jefferies Healthcare Conference, New York, June 7th at 10 a.m. ET
  • William Blair Annual Growth Stock Conference, Chicago, June 16th at 10 a.m. CT

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its proprietary DETERx® technology platform for the treatment of chronic pain and other diseases. The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.

About Xtampza ER

Xtampza™ ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the FDA for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

For Important Safety Information Visit,

Douglas Carlson
Vice President, Corporate Development

Primary Logo

Collegium Pharmaceutical, Inc